BioCardiaA , Inc., a leader in cardiovascular regenerative medicine, today announced positive 12-month results for the randomized Transendocardial Autologous Cells in Ischemic Heart Failure Trial .
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20131118005263&newsLang=en&ndmConfigId=1000639&vnsId=41
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20131118005263&newsLang=en&ndmConfigId=1000639&vnsId=41
No comments:
Post a Comment